In this insightful Q&A, Dr Yosep Chong, Professor of Pathology at the Catholic University of Korea, outlines the revolutionary shift toward “Cytopathology 2.0”- a future defined by scalable, standardised, and AI-powered diagnostics.
Addressing a critical global pathology workforce shortage, Dr Chong highlights how integrating digital infrastructure and artificial intelligence can dramatically bridge the gap. Rather than replacing human expertise, data shows that human-AI collaboration elevates diagnostic accuracy in several areas. The foundational blueprint for this transformation relies on two critical pillars – a robust quality assurance programme, as well as a shift to liquid-based cytology.ย
Ultimately, Dr. Chong provides a practical five-step roadmap for the APAC region: establish strong quality assurance infrastructures, transition to liquid-based cytology, investing in specialised digital pathology systems, piloting AI in high-volume areas, and embracing end-to-end integrated workflows. The technology is mature, the clinical evidence is overwhelming, and the time for regional leadership to drive this transformation is now.
